Nestlé Health Science to acquire The Better Health Company

Nestlé Health Science has agreed to acquire The Better Health Company (TBHC), the parent company of the GO Healthy, Egmont Honey and New Zealand Health Manufacturing businesses from CDH Investments and the group’s founding shareholders.

Under the transaction, Nestlé Health Science will acquire TBHC in its entirety.

TBHC chairman Greg Driscoll said the transaction was a significant milestone.

“It is a huge endorsement in the quality of our products, our people, our capabilities and our brands. We are immensely proud of what our team has achieved”.

“A key part of the success of GO Healthy and Egmont Honey is the reputation that New Zealand has as a producer of high-quality food and health products. While ownership of the brands will change, GO Healthy and Egmont Honey will continue to be proudly New Zealand-produced at our
Auckland and New Plymouth production sites”.

“We are confident that these businesses will continue to grow and develop under the new ownership, benefiting from the significant expertise, capital and networks which Nestlé Health Science brings. The business has excellent growth prospects, particularly in Asia, and these will be enhanced by partnering with a leading global nutrition group the likes of Nestlé Health Science.”

Nestlé Health Science’s Head of Oceania, Asia, Middle East & Africa region Paul Bruhn said the acquisition is a great strategic fit for Nestlé Health Science.

“We are delighted to be adding TBHC to our regional business. TBHC has built the GO Healthy and Egmont Honey brands into excellent businesses and with its manufacturing operations we will be well-placed to grow these brands even further working with Nestlé Health Science”.

“This is our first acquisition ever of a company based in the Asia, Oceania and Africa region and we are excited about the opportunities that this offers us. It’s a perfect fit into our mission of ‘empowering healthier lives through nutrition’.”

Terms of the transaction have not been disclosed. It is expected to close in the fourth quarter of 2022. Closing is subject to regulatory approval from the Overseas Investment Office.